Vilaplana Carnerero, CarlesAznar Lou, IgnacioPeñarrubia María, María TeresaSerrano Blanco, AntoniFernández-Vergel, RitaPetitbò-Antúnez, DolorsGil Girbau, Mª MontserratMarch Pujol, MarianMendive, Juan ManuelSánchez-Viñas, AlbaCarbonell-Duacastella, CristinaRubio Valera, Maria2022-03-042022-03-042020-05-121661-7827https://hdl.handle.net/2445/183766: Background: Adherence problems have negative effects on health, but there is little information on the magnitude of non-initiation and single dispensing. Objective: The aim of this study was to estimate the prevalence of non-initiation and single dispensation and identify associated predictive factors for the main treatments prescribed in Primary Care (PC) for cardiovascular disease (CVD) and diabetes. Methods: Cohort study with real-world data. Patients who received a first prescription (2013-2014) for insulins, platelet aggregation inhibitors, angiotensin-converting enzyme inhibitors (ACEI) or statins in Catalan PC were included. The prevalence of non-initiation and single dispensation was calculated. Factors that explained these behaviours were explored. Results: At three months, between 5.7% (ACEI) and 9.1% (antiplatelets) of patients did not initiate their treatment and between 10.6% (statins) and 18.4% (ACEI) filled a single prescription. Body mass index, previous CVD, place of origin and having a substitute prescriber, among others, influenced the risk of non-initiation and single dispensation. Conclusions: The prevalence of non-initiation and single dispensation of CVD medications and insulin prescribed in PC in is high. Patient and health-system factors, such as place of origin and type of prescriber, should be taken into consideration when prescribing new medications for CVD and diabetes.application/pdfengcc-by (c) Vilaplana Carnerero, Carles et al., 2020https://creativecommons.org/licenses/by/4.0/Malalties cardiovascularsInsulinaCardiovascular diseasesInsulininfo:eu-repo/semantics/article7157082022-03-04info:eu-repo/semantics/openAccess